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Abstract
Background: Tobacco smoke and genetic susceptibility are risk factors for asthma and wheezing.
The aim of this study was to investigate whether there is a combined effect of interleukin-13 gene
(IL13) polymorphisms and tobacco smoke on persistent childhood wheezing and asthma.
Methods:  In the Isle of Wight birth cohort (UK, 1989–1999), five IL13  single nucleotide
polymorphisms (SNPs): rs1800925 (-1112C/T), rs2066960, rs1295686, rs20541 (R130Q) and
rs1295685 were genotyped. Parents were asked whether their children had wheezed in the last 12
months at ages 1, 2, 4 and 10 years. Children who reported wheeze in the first 4 years of life and
also had wheezing at age 10 were classified as early-onset persistent wheeze phenotype; non-wheezers
never wheezed up to age 10. Persistent asthma was defined as having a diagnosis of asthma both
during the first four years of life and at age 10. Logistic regression methods were used to analyze
data on 791 children with complete information. Potential confounders were gender, birth weight,
duration of breast feeding, and household cat or dog present during pregnancy.
Results: Maternal smoking during pregnancy was associated with early-onset persistent wheeze (OR
2.93, p < 0.0001); polymorphisms in IL13 were not (OR 1.15, p = 0.60 for the common haplotype
pair). However, the effect of maternal smoking during pregnancy was stronger in children with the
common IL13 haplotype pair compared to those without it (OR 5.58 and OR 1.29, respectively; p
for interaction = 0.014). Single SNP analysis revealed a similar statistical significance for rs20541 (p
for interaction = 0.02). Comparable results were observed for persistent childhood asthma (p for
interaction = 0.03).
Conclusion: This is the first report that shows a combined effect of in utero exposure to smoking
and IL13 on asthma phenotypes in childhood. The results emphasize that genetic studies need to
take environmental exposures into account, since they may explain contradictory findings.
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Background
It has been suggested that the increased prevalence of
asthma-related phenotypes over the last three decades is
due to exposure to environmental factors [1]. Among such
exposures, environmental tobacco smoke is regarded as
an important risk factor for asthma-related phenotypes
[2,3]. In particular, an effect of maternal smoking during
pregnancy on the development of asthma in offspring has
been proposed [2,4-7]. Parental smoking has also been
reported to be associated with markers of atopy, such as
serum immunoglobulin E (IgE) levels [8]. Interleukin-13
(IL-13) is an important cytokine involved in the IgE path-
way and pathogenesis of asthma [9]. Pulmonary expres-
sion of IL13 is reported to produce inflammation, mucus
hypersecretion, subepithelial fibrosis and eotaxin produc-
tion [10]. It has been reported that exposure to tobacco
smoke during pregnancy was associated with a signifi-
cantly higher production of IL-13 [11,12]. These observa-
tions suggest that part of the effect of exposure to tobacco
on asthma-related phenotypes might be through
cytokines.
Researchers have speculated that individuals may vary in
genetic susceptibility to the physiologic and cellular
response to cigarette smoke exposure and a few studies
have examined gene-smoking interactions for asthma [13-
16]. Wang et al. observed that an interaction between
maternal smoking and the β2 adrenergic receptor gene was
associated with asthma in offspring [15]. Kabesch et al.
demonstrated an interaction between smoking and glu-
tathione S transferase deficiency on asthma [16]. In two
genome-wide screens, interactions between passive
tobacco exposure and chromosome 5q, the region in
which the IL-13 gene (IL13) is located, have been reported
for asthma phenotypes [13,14]. Recently we reported an
interaction of smoking and the IL13 single nucleotide pol-
ymorphism (SNP) rs1800925 related to reduced lung
function in long term tobacco smokers [17].
Compared to wild type IL-13, a non-synonymous poly-
morphism in the IL13  gene, rs20541 (+2044 G/A,
R130Q), has been shown to be associated with more
active IL-13 [18]. It has also been reported that the
rs1800925 (-1112C/T) polymorphism resulted in
enhanced promoter activity [19]. In spite of the impor-
tance of IL-13 in asthma [9,11,12], some studies failed to
show an association between IL13 polymorphisms and
asthma phenotypes [20,21], possibly because of different
prevalence of environmental risk factors such as tobacco
smoke exposure.
Because of the high prevalence (25–30%) of smoking
among women of reproductive age [22] there is a need to
investigate its possible role in the development of asthma-
related phenotypes. In prior assessments of the Isle of
Wight birth cohort study, we have shown that children
with early-onset persistent wheeze have the highest amount
of morbidity in association with atopic sensitization, hos-
pital admission and steroid therapy for asthma [23] To
our knowledge there is no investigation as to whether the
adverse effect of maternal smoking on asthma may result
from an interaction between exposure to tobacco smoke
and cytokine regulating genes. In the current work we test
the hypothesis that an interaction between maternal
smoking during pregnancy and the IL13 gene is associated
with increased risk of early-onset persistent wheeze and per-
sistent childhood asthma in the Isle of Wight birth cohort.
Methods
Population and data
The local Research Ethics Committee approved the study
of children born and enrolled (n = 1,456) between Janu-
ary 1, 1989, and February 28, 1990, on the Isle of Wight,
United Kingdom. Written consent was obtained and chil-
dren were followed up at the ages of 1, 2, 4 and 10 years.
The island is close to the British mainland, semi-rural,
with no heavy industry. The population is 99% Cauca-
sian.
At birth, weight was obtained from hospital records and
parents were asked about their age and exposures during
pregnancy. At subsequent follow-ups, a questionnaire was
administered seeking information on exposure to tobacco
smoke, breast feeding, and wheezing in the cohort chil-
dren.
Exposure to tobacco smoke
Information on tobacco smoking by mothers (during
pregnancy and later), fathers, or any other individual
inside the home was recorded at recruitment and updated
at each follow-up. Exposures to environmental tobacco
smoke (ETS) in the household and maternal smoking
during pregnancy were combined and classified into three
groups. When mothers did not smoke during pregnancy
and there was no exposure to household ETS in children
up to the age of 10, children were categorized as "ETS-0".
When mothers did not smoke during pregnancy, but
household members smoked within the home at some
point up to the child's age of 10 years, the exposure status
was categorized as "ETS-1". When mothers smoked dur-
ing pregnancy and the children were also exposed to
household ETS at some point up to the age of 10, the
exposure was categorized as "ETS-2". None of the children
had mothers who smoked during pregnancy but no expo-
sure to household tobacco smoke after birth.
Definition of wheeze phenotypes and persistent childhood 
asthma
At each of the four follow-ups at ages 1, 2, 4, and 10 years,
"current wheeze" was recorded if wheezing occurred on atRespiratory Research 2008, 9:2 http://respiratory-research.com/content/9/1/2
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least one occasion in the previous 12 months. Parents
were also asked whether the child had any wheeze episode
between ages 4 and 10. Children were then categorized
into wheezing phenotypes as follows: non-wheezers never
wheezed in the first decade of life, early-onset persistent
wheezers had wheezed in the first 4 years of life and still
wheezed at age 10, while late-onset persistent wheezers had
wheezing onset after 4 years of age and still wheezed at age
10. Early transient wheezers began wheezing in the first 4
years but stopped at least 12 months before age 10.
Details on wheeze phenotypes from 1 to 10 years of this
cohort have been reported previously [23].
Asthma was based on investigator diagnosis of asthma
and has been described in previous reports of this cohort
[24]. Persistent childhood asthma was defined as having
asthma diagnosis at age 10 in addition of at least one
asthma diagnosis in the first four years of life, the control
group included children with no asthma diagnosis at any
time point, case-cohort analysis.
DNA isolation and IL13 genotyping
Anticoagulated whole blood samples were obtained at the
10-year interview and stored frozen (n = 921). Genomic
DNA was isolated from these samples using QIAamp
DNA Blood Kits (Qiagen, Valencia, CA) or the ABI
PRISM™ 6100 Nucleic Acid PrepStation (Applied Biosys-
tems, Foster City, CA). Polymorphisms in the IL13 gene
were examined using the SNPper and Applied Biosystems
databases [25]. Genotyping was conducted by fluorogenic
5' nuclease chemistry PCR using Assays on Demands kits
cycled on a 7900HT Sequence Detection System (Applied
Biosystems, Foster City, CA), or biotin-streptavidin-based
pyrosequencing performed on PSQ-96 instrumentation
(Biotage AB, Uppsala, Sweden).
Five SNPs from the IL13 gene were used in this study:
rs1800925 in the 5' promoter region, rs2066960 in intron
1, rs1295686 in intron 3 at the intron/exon boundary,
rs20541 in exon 4 and rs1295685 in the 3' untranslated
region (UTR) of exon 4. The rs20541 is a coding variant
with the common allele (G) coding for arginine and the
minor allele (A) encoding glutamine at amino acid 144.
Because IL13 is a small gene (2.9 kb), only a few SNPs
were needed for a reasonable assessment of genetic asso-
ciations. The SNPs in this report build upon the haplotype
tagging (ht)-SNPs indicated by Tarazona-Santos and
Tishkoff in a European population [26] and they include
those most commonly examined for association with
asthma and related phenotypes in other previous studies
[27-31].
Statistical analysis
Each SNP was tested for Hardy-Weinberg equilibrium
using Haploview 3.2 software [32]. Estimates of linkage
disequilibrium (LD) between SNPs were calculated using
D' and r2 [33]. PHASE 2.0.2 was employed to build the
most likely pair of haplotypes (diplotypes) and their
probability for each child [34], using all five SNPs. In the
analysis of individual SNPs and haplotype pairs, geno-
types with low frequencies were combined [35,36].
Using SAS/STAT® version 9.1, statistical analysis was per-
formed on the data only from children who had complete
information on IL13  genotypes, exposure to tobacco
smoke and wheeze phenotypes. Chi-square tests were
used to compare the sample used in the analysis with that
which was followed up at age 10. To investigate main
effects and interactions between smoke exposures and
genetic polymorphisms for the wheeze phenotypes, a
multinomial logistic regression analysis (PROC GLIM-
MIX, SAS) was conducted. For analysis of persistent
asthma simple logistic regression (PROC LOGISTICS,
SAS) was used.
To evaluate the associations between wheeze phenotypes
and other variables of interest, non-wheezers were used as
the control group. Persistent childhood asthma was
treated as a dichotomous variable (yes, no). Confounders
were chosen based on their importance in studying
wheeze phenotypes in a prior report of the Isle of Wight
cohort [37]. Potential confounders (table 1) were: gender,
low birth weight (< 2,500 grams versus ≥ 2,500 grams),
breast feeding (< three months and ≥ three months),
household cat present during pregnancy (yes, no) and
household dog present during pregnancy (yes, no).
Results
Data on IL13 genotypes, exposure to tobacco smoke and
wheeze phenotypes were available for 791 children. The
percentages of children who wheezed and those who had
ETS-0 were higher in the sample used in the analyses com-
pared to all those who were followed up to age 10 (table
1). More than half of the children were exposed to tobacco
smoke up to age 10 (23.3% during and after pregnancy;
31.5% after pregnancy, table 1).
For IL13 genotypes, all five SNPs were in Hardy-Weinberg
equilibrium and three of the SNPs (rs1295686, rs20541
and rs1295685) demonstrated linkage disequilibrium
based on D' (≥ 0.95) and r2 (≥ 0.89, Figure 1). Therefore,
haplotypes were inferred using rs20541 from this block
and the other two SNPs (rs1800925 and rs2066960). Due
to the limited number of children homozygous for minor
alleles at all SNPs (less than 5%, table 2), minor allele
homozygous and heterozygous genotypes were grouped
together. Among haplotype pairs, CCG/CCG (for SNPs
ordered rs1800925, rs2066960, rs20541) had the highest
frequency (0.48, table 3). The estimated probability for
CCG/CCG as the best pair was 1.0 in 99% of children andRespiratory Research 2008, 9:2 http://respiratory-research.com/content/9/1/2
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at least 0.89 in the rest (results not shown). All other hap-
lotype pairs had frequencies between 0.019–0.155. In
addition, there were probabilities as low as 0.5 that were
identified as the best pair for haplotype pairs other than
CCG/CCG. Thus, haplotype pairs other than CCG/CCG
were combined [35,36].
To determine the associations of IL13, exposure to
tobacco smoke and their combination on wheeze pheno-
types, we conducted multinomial logistic regression.
Crude analysis showed that, with the exception of
rs2066960 with early-transient wheeze, genotypes of indi-
vidual SNPs or haplotype pairs were not associated with
early-onset persistent wheeze (table 4, reference:non-
wheezers) or other wheeze phenotypes; maternal smok-
ing during pregnancy (ETS-2) was associated with early-
onset persistent wheeze (p < 0.0001, table 4).
In a stratified analysis, the combined effect of IL13 geno-
types and exposure to tobacco smoke on early-onset persist-
ent  wheeze was assessed. In the strata with common
(homozygous major allele)IL13 genotypes, the effects of
maternal smoking during pregnancy on early-onset persist-
ent wheeze were significant (figure 2). In particular, figure
2 shows for the five SNPs and for the IL13 haplotype that
common genotypes were not related to a higher preva-
lence of wheezing in non-smoke exposed children (white
bars). However, under the condition of prenatal smoke
exposure, children with common genotypes showed a sta-
tistically increased risk of early-onset persistent wheezing
(black bars). This combined effect was not found for chil-
dren who had minor homozygous or heterozygous geno-
types.
Table 5 shows a model to evaluate the statistical interac-
tion of CCG/CCG and smoking. For early-onset persistent
wheeze, the interaction term between ETS-2 and CCG/
CCG showed statistical significance (p < 0.014, table 5).
For this combined effect the two different ORs (OR = 2.59
and OR = 5.89) are calculated based on two different sce-
narios. In the first case (OR = 2.59), children exposed to
maternal smoking during pregnancy are the reference and
the effect of the gene is added to this equation, thus, given
this reference, the effect of maternal smoking during preg-
Table 1: Comparison of children with a follow-up at age 10 and the subset used in the analysis
Numbers at age 10 (%) Numbers used in the analysis (%) χ2 p value
Variable Total 1,373 791
Wheeze Phenotype Early-onset persistent* 139 (12.7) 105 (13.3) 0.60
Late-onset persistent† 81 (7.4) 70 (8.9)
Early transient‡ 259 (23.6) 190 (23.9)
Non-wheezer§ 617 (56.3) 426 (53.9)
Missing 277 0
Birth weight ≥2500 grams 1287 (96.3) 736 (96.0) 0.75
<2500 grams 49 (3.7) 31 (4.0)
Missing 37 24
Exposure to tobacco smoke ETS-0 617 (45.2) 381 (48.2) 0.22
ETS-1 430 (31.5) 249 (31.5)
ETS-2 319 (23.3) 161 (20.3)
Missing 7 0
Gender Girl Boy 676 (49.2) 388 (49.3) 0.98
697 (50.8) 399 (50.7)
Breast fed ≥3 months 470 (41.7) 322 (42.8) 0.67
<3 months 657 (58.3) 430 (57.2)
Missing 246 39
Household cat during pregnancy Yes 453 (33.2) 269 (34.0) 0.68
No 912 (66.8) 521 (66.0)
Missing 8 1
Household dog during pregnancy Yes 395 (28.9) 240 (30.4) 0.48
No 970 (71.1) 550 (69.6)
Missing 8 1
* Onset of wheeze in the first 4 years, still present at age 10.
† Onset of wheeze after age 4 years, still present at age 10.
‡ Wheeze only in the first 4 years.
§ No wheeze up to age 10.
ETS-0, mothers did not smoke during pregnancy and children not exposed to household ETS; ETS-1, mothers did not smoke during pregnancy, but 
children were exposed to household ETS; ETS-2, mothers smoked during pregnancy and children were exposed to household ETSRespiratory Research 2008, 9:2 http://respiratory-research.com/content/9/1/2
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nancy is eliminated from the equation. In the second case
(OR = 5.89), children with the CCG/CCG haplotype pair
are the reference and maternal smoking during pregnancy
is introduced to this setting. In addition to the haplotype
analysis, single SNP analysis revealed a significant interac-
tion term between rs20451 (GG versus GA+AA) and ETS-
2 on early-onset persistent wheeze (p  for interaction <
0.020, data not shown).
To determine the effect of minor haplotype pairs (fre-
quency = 0.087, table 3), the analyses were repeated by
excluding this group and results did not change signifi-
cantly (data not shown).
When analyzing asthma, 68 subjects had persistent
asthma. The control group were 533 subjects who did not
have any asthma diagnosis during the first decade of life.
When analyzing asthma instead of wheezing, the interac-
tion between ETS-2 and IL13 haplotype pairs was statisti-
cally significant (p = 0.03) for persistent asthma as it was
for persistent wheeze. Children with a CCG/CCG haplo-
type pair had an OR of 5.57 (95% CI 2.13 to 14.63, p =
0.0005) for ETS-2 on persistent asthma. For subjects with
haplotype pairs other than CCG/CCG, the OR was 1.32
(95% CI 0.57 to 3.04, p = 0.587).
Among confounders, the presence of a household cat or
dog during pregnancy was protective and male sex was a
risk factor for early-onset persistent wheeze (table 5).
Discussion
This study investigated the combined effect of exposure to
tobacco smoke and haplotype pairs of the IL13 gene on
wheeze phenotypes in the first decade of life using the
data from the Isle of Wight birth cohort. Maternal smok-
ing during pregnancy was associated with early-transient
and early-onset persistent wheeze. No independent effect
for the IL13 gene was detected. However, common variant
of IL13 gene polymorphisms were observed to increase
the adverse effect of maternal smoking during pregnancy
on early-onset persistent wheeze, the phenotype with the
highest morbidity [23]. A similar association was
observed for the persistent asthma phenotype. Tobacco
smoke exposure after pregnancy did not modify the asso-
ciation of IL13 and wheezing nor asthma.
In this study, the information was available from a subset
of children who were followed up at age 10 and who
agreed to provide blood for genotyping. Although these
children appeared to have slightly (~3%) more wheeze
Table 2: Genotypes for IL13 single nucleotide polymorphisms 
(SNPs)
SNP Position (bp) Location Genotype Frequency (%)
rs1800925 
(-1112C/T)
132,020,708 Promoter CC 577 (63.6)
CT 295 (32.5)
TT 35 (3.9)
Total 907 (100.0)
rs2066960 132,022,334 Intron 1 CC 729 (81.5)
AC 157 (17.6)
AA 8 (0.9)
Total 894 (100.0)
rs1295686 132,023,742 Intron 3 CC 483 (64.6)
CT 240 (32.1)
TT 25 (3.3)
Total 748 (100.0)
rs20541 
(R130Q)
132,023,863 Exon 4 GG 583 (64.4)
GA 291 (32.1)
AA 32 (3.5)
Total 906 (100.0)
rs1295685 132,024,344 Exon 4 GG 584 (64.5)
GA 280 (30.9)
AA 41 (4.5)
Total 905 (100.0)
Gene annotation is based on SNPper [25]
IL13: interleukin-13 gene; n, number of samples used in genetic 
studies; bp, basepairs.
Using the Haploview program [32], three single nucleotide  polymorphisms of the interleukin 13 gene appeared to be in a  block Figure 1
Using the Haploview program [32], three single 
nucleotide polymorphisms of the interleukin 13 gene 
appeared to be in a block. r2, a pair wise linkage disequi-
librium determinant [33], is shown.Respiratory Research 2008, 9:2 http://respiratory-research.com/content/9/1/2
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and less exposure to tobacco smoke in comparison to all
children who were followed up at age 10, these differences
were not significant. The presence of a selection bias could
result in a violation of the Hardy-Weinberg equilibrium
and different allele frequencies than other Caucasian pop-
ulations [29,38]. The latter scenario was not present,
hence, a selection bias is unlikely.
The wheeze phenotypes were specified at age 10 based on
longitudinal records from ages 1, 2, 4 and 10. This
strengthens the study as we used longitudinal wheeze
phenotypes instead of an outcome measured at a single
cross section. To avoid recall bias, the analysis was
restricted to children who were seen prospectively with
information at all study visits [23]. Previously, we have
shown that a preceding diagnosis of asthma was less likely
to produce biased reports in later follow-ups [24].
Information on individual SNPs was used and the most
likely pairs of haplotypes were estimated from genotype
data. We demonstrated a significant association between
exposure to maternal smoking during pregnancy and
early-onset persistent wheeze when children had the com-
mon variant for each individual SNP as well as haplotype
pairs.
One motivation for using haplotype pairs was the consist-
ent pattern observed for the combined effect of ETS-2 and
all markers (individual SNPs and haplotype pairs) on
early-onset persistent wheeze (Figure 2). Additionally, it has
been suggested, specifically for IL13 [31], that haplotype
analysis could confer more information than individual
marker analysis [39,40]. Haplotype pair analysis may mis-
classify genotypes when parents' genetic information is
not available (ambiguous phase). However, the probabil-
ity of having CCG/CCG, the major haplotype pair, was
1.00 in 429 out of 435 children with this genotype (the
probability for the other 6 children was 0.89). The distri-
bution of the data, with respect to minor haplotypes, did
not allow testing for their interactions with tobacco
smoke exposure. However, when children homozygous
for minor haplotypes (frequency = 0.071, table 3) were
removed from the analysis, the results did not change sub-
stantially.
Previous studies have shown an increased risk of asthma
in children who were exposed to tobacco during preg-
nancy [3]. In a prior examination of this cohort, a possible
association between exposures during pregnancy and
early-onset persistent wheeze was suggested [37]. Addition-
ally, several studies have suggested a gene-environment
interaction for the effect of tobacco smoke exposure and
Table 4: Unadjusted Odds Ratios, multinomial logistic regression, for covariates on wheeze phenotypes
Early-transient Early-onset persistent Late-onset
Covariate OR, p-value OR, p-value OR, p-value
rs1800925, CT-TT vs CC 0.99, 0.971 0.98, 0.928 0.91, 0.743
rs2066960, CA-AA vs CC 1.61, 0.032 1.36, 0.273 1.24, 0.524
rs1295686, CT-TT vs CC 1.02, 0.922 1.12. 0.642 1.02, 0.937
rs20541, GA-AA vs GG 1.17, 0.393 1.12, 0.614 1.55, 0.096
rs1295685, GG vs GA-AA 1.16, 0.411 1.15, 0.535 1.51, 0.116
others vs CCG/CCG 1.10, 0.592 0.93, 0.729 1.10, 0.709
ETS-2 vs ETS-0 1.70, 0.022 2.93, <0.0001 0.57, 0.173
ETS-1 vs ETS-0 1.57, 0.023 1.86, 0.018 0.61, 0.861
‡ The reference was the group who never report wheeze up to age 10 (n = 426).
CCG/CCG is the most common haplotype pair constructed based on rs1800925, rs2066960 and rs20541, using PHASE 2.0.2 software [34]. ETS-0, 
mothers did not smoke during pregnancy and children not exposed to household ETS; ETS-1, mothers did not smoke during pregnancy, but 
children were exposed to household ETS; ETS-2, mothers smoked during pregnancy and children were exposed to household ETS
Table 3: Frequency of haplotypes and haplotype pairs for five 
single nucleotide polymorphisms (rs1800925, rs2066960, 
rs20541) of IL13, inferred from genotype data of 912 children
Frequency (SE)
Haplotype CCG 0.687 (0.003)
TCA 0.105 (0.003)
TCG 0.067 (0.002)
CCA 0.043 (0.002)
CAG 0.040 (0.003)
CAA 0.027 (0.002)
TAA 0.020 (0.003)
TAG 0.009 (0.002)
Haplotype pair(s) CCG/CCG 0.478
CCG/minor haplotypes* 0.451
minor haplotypes/minor 
haplotypes†
0.071
PHASE 2.0.2. was used for this analysis [34].
* This group consists of, with a frequency of:
CCG/TCA, 0.155; CCG/TCG, 0.088; CCG/CCA, 0.055; CCG/CAG, 
0.054;
CCG/TAA, 0.043; CCG/CAA, 0.038; CCG/TAG, 0.019;
† This group consists of, with a frequency of:
TCG/TCA, 0.020; CCA/TCA, 0.012; other haplotypes, < 0.010
IL13: interleukin-13Respiratory Research 2008, 9:2 http://respiratory-research.com/content/9/1/2
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asthma phenotypes [13,14,16]. Specifically, in two
genome-wide screens, Colilla et al and Meyers et al
reported that exposure to tobacco modifies the linkage
between 5q, the region containing IL13, and asthma phe-
notypes [13,14]. The current study demonstrates a sce-
nario in which a gene modifies the effect of tobacco
smoke exposure during pregnancy but not after, thus,
time of the exposure may be of critical importance in
gene-environment interaction studies. The finding of an
interaction between IL13 and ETS in the present study sug-
gests that negative reports for the effect of a candidate
gene for IL13 and asthma [20,21], could be explained by
a failure to take into account environmental exposures. It
is therefore of utmost importance, for genetic studies, to
describe environmental exposures in the target popula-
tion.
Most of the previous studies, including a report on the Isle
of Wight cohort [41], suggest that the minor alleles of IL13
SNPs rs20541 (R130Q) and rs1800925 (-1112C/T) are
associated with increased adverse effects [10,17-19,42]. In
the current study we observed that children who had the
common genotype for IL13 polymorphisms (haplotype
pairs or SNP rs20541) have increased risk of early onset per-
sistent wheeze and persistent childhood asthma in relation
to maternal smoking during pregnancy.
Our finding for common IL13 variants to be a risk factor
when mothers smoked during pregnancy is unexpected.
Nevertheless, the observed association is statistically sig-
nificant and cannot be explained by chance (p = 0.014).
Additionally, we see a constant pattern for the effect of
smoking across the SNPs and their haplotypes. This latter
observation also suggests that it is less likely that the find-
ings are due to a random effect. An unexpected finding for
the effect of SNP rs20541 alleles on persistent wheeze is
not scientifically untenable as the interplay between genes
and environment is complex. Similar discrepancy has
been shown for CD14, which turned out to be an interest-
ing gene-environment interaction [43].
It has been suggested that tobacco smoke increases IL-13
and there are some reports on the combined effects of
IL13 polymorphisms or other genetic variants in the IL13
region on asthma-related outcomes [11-14,44].
Liu et al. reported a synergistic effect of smoking and IL13
promoter polymorphism on the level of serum IgE [44],
and genome-wide analyses have suggested a gene-envi-
ronment interaction for the effect of tobacco exposure on
asthma [13,14]. Noakes and colleagues demonstrated that
cord blood cells produce significantly higher levels of IL-
13 in response to both house dust mite and ovalbumin
when newborns are exposed to tobacco smoke during
pregnancy [11]. This suggests that prenatal exposure to
tobacco elicits immunological effects. In our analysis, the
interaction between tobacco exposure and IL13 polymor-
phisms was present in those who were exposed during
and after pregnancy, but was not evident for the group
with the same polymorphisms who were exposed only
after pregnancy. As there was no group of children that
was exposed only during pregnancy, it is not possible to
The vertical axis is the percentage of early-onset persistent wheezers divided by the sum of early-onset persistent wheezers and  non-wheezers (n = 791) Figure 2
The vertical axis is the percentage of early-onset persistent wheezers divided by the sum of early-onset persistent 
wheezers and non-wheezers (n = 791). For each genotype strata, reference was ETS-0. *, p value < 0.05; **, p value < 
0.001. ETS-0, mothers did not smoke during pregnancy and children were not exposed to household ETS; ETS-1, mothers did 
not smoke during pregnancy, but children were exposed to household ETS; ETS-2, mothers smoked during pregnancy and chil-
dren were exposed to household ETS. SNP, single nucleotide polymorphism; rs1800925, rs2066960, rs1295686, rs20541 and 
rs1295686 are five SNPs within the interleukin13 gene. SNPs rs1295686, rs20541, and rs1295686 were in a block. Therefore 
haplotype analysis was based on SNPs rs1800925, rs2066960, and rs20541. # The most common haplotype pair, CCG/CCG, 
constructed based on SNPs rs1800925, rs2066960, and rs20541, using PHASE 2.0.2 software [34].Respiratory Research 2008, 9:2 http://respiratory-research.com/content/9/1/2
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distinguish definitively the effect of tobacco exposure
before and after pregnancy. However, considering both
the relatively short time of pregnancy and the large differ-
ence of risk between the two exposed groups, we suggest
that exposure to tobacco during pregnancy has more
influence on asthma than tobacco exposure after preg-
nancy.
In summary, in a sub-sample of the Isle of Wight cohort,
the combined effect of exposure to tobacco smoke during
pregnancy and the common haplotype pair of the IL13
gene resulted in an increased relative risk of early-onset per-
sistent wheeze and asthma. For tobacco smoke exposure
later in childhood we did not observe this association. The
IL13 gene did not pose a risk in its own right. These results
demonstrate that the association between exposures to
environmental risk factors, like tobacco smoke, can be
modified by gene polymorphisms. Given that there are
various patterns and prevalences of exposure to tobacco
smoke in different populations, this study suggests that
negative reports of genetic association studies may be due
to differences in environmental exposures. We propose
that the next step in the investigation of the interaction
Table 5: Adjusted estimates, multinomial logistic regression model, for the effect of smoke exposure and the major haplotype pair 
(CCG/CCG)† of IL13 gene on wheeze phenotypes
Variable Function‡ estimate p value Odds ratio & 95% CI
Boy 1 0.52 0.006 1.69 1.16 2.49
2 0.64 0.009 1.90 1.18 3.06
3 0.29 0.275 1.33 0.80 2.23
Birth weight < 2500 g 1 -1.11 0.012 0.33 0.14 0.78
2 -0.10 0.887 0.91 0.24 3.49
3 -0.14 0.863 0.87 0.19 4.09
Breast feeding < 3 months 1 -0.03 0.170 0.97 0.93 1.01
2 -0.06 0.037 0.94 0.88 0.99
3 0.05 0.116 1.05 0.99 1.11
Having a cat during pregnancy 1 -0.06 0.776 0.94 0.64 1.40
2 -0.49 0.071 0.62 0.36 1.04
3 -0.02 0.949 0.98 0.57 1.69
Having a dog during pregnancy 1 0.00 0.980 0.99 0.67 1.49
2 -0.55 0.050 0.58 0.33 1.00
3 -0.25 0.401 0.78 0.43 1.40
ETS-2 1 0.52 0.130 1.67 0.86 3.28
2 0.25 0.573 1.29 0.54 3.08
3 -0.76 0.245 0.47 0.13 1.68
CCG/CCG 1 -0.06 0.849 0.95 0.54 1.67
2 -0.57 0.163 0.57 0.25 1.26
3 0.02 0.945 1.02 0.52 2.01
ETS-2 × CCG/CCG 1 ¥ -0.35 0.491 0.66 0.28 1.54
2 ¥1.52 0.014 2.59 1.04 6.44
3 ¥0.70 0.409 2.06 0.45 9.33
ETS-1 1 0.42 0.161 1.52 0.85 2.74
2 0.40 0.289 1.49 0.71 3.09
3 0.16 0.687 1.17 0.54 2.52
ETS-1 × CCG/CCG ¥ 1 ¥ 0.25 0.566 1.21 0.65 2.26
2 ¥ 0.48 0.410 0.92 0.40 2.07
3 ¥ -0.45 0.459 0.65 0.24 1.76
ETS-0, mothers did not smoke during pregnancy and children not exposed to household ETS; ETS-1, mothers did not smoke during pregnancy, but 
children were exposed to household ETS; ETS-2, mothers smoked during pregnancy and children were exposed to household ETS.
† The most common haplotype pair, inferred from genotype data of five single nucleotide polymorphisms of interleukin 13 gene, rs1800925, 
rs2066960 and rs20541, using PHASE 2.0.2 software [34].
‡ correspond to a specific wheeze phenotype: Function 1: early-transient (n = 190), 2: early-onset persistent (n = 105), 3: late-onset (n = 70). The 
reference was the group who never report wheeze up to age 10 (n = 426).
× Denotes an interaction.
¥ For interaction terms, GLIMMIX estimates the Odds Ratio (95% CI) of the combined effect based on the parameter estimate of the main and the 
interaction effect. For the interaction term, we present the Odds Ratio for two combined effects, but not the statistical significant estimate of the 
individual interaction term. For example for early-onset persistent wheeze (function 2), the OR for children with the CCG/CCG genotype who had 
mothers who smoked during pregnancy is exponential (1.5223 + [-0.57]) = 2.59. The OR for maternal smoking during pregnancy (ETS-2 = 1) in 
children having the CCG/CCG genotype is exponential (-0.2512 + 1.5223) = 5.89 (95% CI: 2.47, 14.1). The difference in the combined effects 
results from different reference groups (no smoking during pregnancy and not the CCG/CCG genotype, respectively).Respiratory Research 2008, 9:2 http://respiratory-research.com/content/9/1/2
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between IL13 and exposure to tobacco smoke is to exam-
ine the influence of ETS exposure on IL13 expression.
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